XML 68 R44.htm IDEA: XBRL DOCUMENT v3.26.1
Stock-Based Compensation, Stock Option Activity (Details) - USD ($)
3 Months Ended 12 Months Ended
Oct. 30, 2025
Feb. 25, 2025
Jan. 29, 2025
Dec. 30, 2022
Dec. 31, 2025
Mar. 31, 2025
Jun. 30, 2024
Dec. 31, 2025
Dec. 31, 2024
Weighted Average Exercise Price [Roll Forward]                  
Options outstanding, beginning balance (in dollars per share)           $ 6.08   $ 6.08  
Granted (in dollars per share)               1.09  
Cancelled (in dollars per share)               32.98  
Forfeited (in dollars per share)               4.74  
Expired (in dollars per share)               7.39  
Options outstanding, ending balance (in dollars per share)         $ 4.55     4.55 $ 6.08
Vested and expected to vest (in dollars per share)         4.55     4.55  
Exercisable (in dollars per share)         $ 5.82     $ 5.82  
Weighted Average Remaining Contractual Life and Aggregate Intrinsic Value [Abstract]                  
Options outstanding, weighted average remaining contractual life               4 years 11 months 15 days 7 years 1 month 9 days
Granted, weighted average remaining contractual life               6 years 8 months 1 day  
Vested and expected to vest, weighted average contractual life               4 years 11 months 15 days  
Exercisable, weighted average contractual life               6 years 5 months 8 days  
Options outstanding, aggregate intrinsic value, beginning balance           $ 50,439   $ 50,439  
Granted, aggregate intrinsic value               0  
Cancelled, aggregate intrinsic value               0  
Forfeited, aggregate intrinsic value               0  
Expired, aggregate intrinsic value               0  
Options outstanding, aggregate intrinsic value, ending balance         $ 585,272     585,272 $ 50,439
Vested and expected to vest, aggregate intrinsic value         585,272     585,272  
Exercisable, aggregate intrinsic value         $ 224     $ 224  
Unamortized Stock Compensation Expense [Abstract]                  
Issuance of common stock for consulting agreement (in shares)       378,787          
Weighted-average grant date fair value, granted (in dollars per share)               $ 1.28 $ 4.7
Common Stock [Member]                  
Unamortized Stock Compensation Expense [Abstract]                  
Issuance of common stock for consulting agreement (in shares) 100,000 100,000 50,000   100,000 150,000 100,000   100,000
Stock Options [Member]                  
Number of Shares [Roll Forward]                  
Options outstanding, beginning balance (in shares)           5,373,063   5,373,063  
Granted (in shares)               1,246,500  
Cancelled (in shares)               (10,500)  
Forfeited (in shares)               (447,304)  
Expired (in shares)               (226,735)  
Options outstanding, ending balance (in shares)         5,935,024     5,935,024 5,373,063
Vested and expected to vest (in shares)         5,935,024     5,935,024  
Exercisable (in shares)         3,911,854     3,911,854  
Unamortized Stock Compensation Expense [Abstract]                  
Unamortized stock-based compensation expense         $ 6,339,403     $ 6,339,403  
Period for recognition               1 year 2 months 23 days  
Weighted-average grant date fair value, granted (in dollars per share)               $ 1.28  
Performance-Based Restricted Stock Units [Member]                  
Unamortized Stock Compensation Expense [Abstract]                  
Granted restricted stock units (in shares)               800,000 0
Stock-based compensation expense               $ 0